Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroendocrine Tumors × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Urinary Bladder Neoplasms 9 Neoplasms 8 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Breast Neoplasms 4 Lymphoma 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sezary Syndrome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Everolimus 13 Octreotide 6 Magnetic Resonance Spectroscopy 5 lanreotide 4 Sunitinib 4 gallium Ga 68 dotatate 3 cabozantinib 3 arginyllysine 3 Specimen Handling 3 Nivolumab 3 Etoposide 3 Carboplatin 3 Bevacizumab 3 telotristat ethyl 2 surufatinib 2 pembrolizumab 2 pazopanib 2 pasireotide 2 lutetium Lu 177 dotatate 2 X-Rays 2 Temozolomide 2 Phantoms, Imaging 2 Oxaliplatin 2 Ipilimumab 2 Erlotinib Hydrochloride 2 Doxorubicin 2 Cisplatin 2 Capecitabine 2 3-Iodobenzylguanidine 2 177Lu-DOTA-JR11 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡